Internal Medicine, Gastroenterology · Glendale, AZ
NPI
1922074012
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5823 W Eugie Ave, Ste A
Glendale, AZ, 85304
Phone (602) 843-1265
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
504 services
Medicare patients, 2024
311
Average age 73
Drug cost, 2024
$889K
1,461 prescriptions
Company payments, 2024
$1,226
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jodie K Labowitz was code 99214 (office e&m - established), 118 times for 95 patients. In total Jodie K Labowitz billed 504 services in 18 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 118 | 95 | $89.49 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 79 | 79 | $103.25 | $8,157 |
| 45385 Colonoscopy - Lesion Removal | Facility | 57 | 57 | $200.84 | $11K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 45 | 45 | $173.77 | $7,820 |
| 99213 Office E&M - Established | Office | 45 | 44 | $63.54 | $2,859 |
| 43239 Upper GI Endoscopy | Facility | 42 | 42 | $78.26 | $3,287 |
| 99204 Office E&M - New | Office | 41 | 41 | $98.25 | $4,028 |
| 99203 Office E&M - New | Office | 21 | 21 | $66.42 | $1,395 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 18 | 18 | $174.15 | $3,135 |
| 43235 Upper GI Endoscopy | Facility | 16 | 16 | $69.70 | $1,115 |
By year: 2022 $82K for 803 services; 2023 $82K for 855 services; 2024 $55K for 504 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jodie K Labowitz prescribed most often to Medicare patients was Omeprazole, with 258 prescriptions and refills. In total Jodie K Labowitz wrote 1,461 Medicare prescriptions that cost $889K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 258 | 605 | 103 | $3,569 |
| Pantoprazole Sodium Generic | 159 | 337 | 54 | $2,061 |
| Famotidine Generic | 115 | 250 | 46 | $1,572 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 76 | 76 | 74 | $5,403 |
| Nortriptyline Hcl Generic | 66 | 128 | 19 | $771 |
| Dicyclomine Hcl Generic | 59 | 99 | 24 | $816 |
| Linzess Linaclotide | 52 | 72 | 21 | $37K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 50 | 50 | 50 | $756 |
| Sucralfate Generic | 48 | 82 | 17 | $1,569 |
| Mesalamine Generic | 38 | 90 | 12 | $23K |
| Fluoxetine Hcl Generic | 37 | 93 | 12 | $289 |
| Amitriptyline Hcl Generic | 34 | 73 | 12 | $272 |
| Balsalazide Disodium Generic | 27 | 53 | Under 11 | $4,660 |
| Esomeprazole Magnesium Generic | 21 | 61 | Under 11 | $675 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 21 | 33 | 11 | $388 |
Brand drugs: 206 claims; generic drugs: 1,255 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Jodie K Labowitz $1,226 ($1,226 in general payments such as food, travel and fees) from 21 companies. The largest payer was Gilead Sciences, Inc. with $214.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 10 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $200 |
| Genzyme Corporation SNY | 8 | $174 |
| Abbvie Inc. ABBV | 5 | $108 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $74.68 |
| Ardelyx, Inc. ARDX | 3 | $57.41 |
| Pfizer Inc. PFE | 3 | $57.07 |
| Celgene Corporation BMY | 3 | $53.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $52.52 |
| Celltrion USA Inc. 068270.KS | 2 | $32.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.